GlassScriptPhysician profile
Mohan C Madala
NPI 1295949030
$6,217.08
in general payments reported to CMS, 2019-2025
29 companies · $847 in 2025
The $847 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $259 · 2021: $1,067 · 2022: $1,348 · 2023: $1,201 · 2024: $1,031 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,079.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $878.68 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $874.83 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $578.51 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $529.35 | 2020-2025 | Camzyos, Eliquis |
| Inari Medical, INC. | $508.76 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $402.28 | 2021-2025 | Wainua, Andexxa, Brilinta |
| Abbott Laboratories | $371.66 | 2021-2025 | Cardiomems, Accent, Optis |
| Pfizer INC. | $354.93 | 2019-2025 | |
| Boston Scientific Corporation | $335.70 | 2019-2023 | Watchman Access System, Watchman, Watchman Flx |
| Astellas Pharma US INC | $199.94 | 2021 | |
| Philips North America LLC | $128.63 | 2019-2024 | (Ck4) Mcot |
| Stryker Corporation | $123.32 | 2025 | Clottriever Bold Catheter, Venacore Thrombectomy Catheter |
| Impulse Dynamics (USA) INC. | $122.37 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $121.01 | 2019-2023 | |
| Baxter Healthcare | $106.17 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $104.26 | 2025 | Amvuttra |
| Actelion Pharmaceuticals US, INC. | $74.83 | 2019 | |
| Abiomed | $66.60 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.79 | 2022-2023 | Jardiance |
| Medtronic, INC. | $59.70 | 2023-2025 | Corevalve Evolut R |
| Biosense Webster, INC. | $35.97 | 2023-2024 | Carto 3, Qdot Micro Catheter |
| Shockwave Medical, INC | $34.75 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Teleflex LLC | $30.39 | 2019-2023 | Trapliner |
| Chiesi USA, INC. | $29.90 | 2022 | |
| Angiodynamics, INC. | $19.97 | 2022 | |
| Cardiva Medical, INC. | $19.86 | 2022 | |
| Livanova USA, INC. | $18.60 | 2022 | |
| Kestra Medical Technology Services, INC. | $18.33 | 2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4.99 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohan Madala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.